期刊文献+

骨髓间充质干细胞对小鼠肝硬化模型的作用研究

Research of bone marrow mesenchymal stem cells on the cirrhosis model in mice
暂未订购
导出
摘要 目的探索小鼠骨髓间充质干细胞(BMSCs)的培养和其肝硬化模型的制备,以及两者之间的相互作用。方法首先,提取小鼠骨髓,移至培养瓶中,根据全骨髓贴壁法的原理培养干细胞;然后,采用CCl4为主的方法对小鼠进行肝硬化模型的制备;最后,把培养成功的骨髓干细胞通过肝动脉和尾静脉途径移植治疗造模成功的肝硬化小鼠,观察疗效。结果根据多种单克隆抗体的表达,使用流式细胞仪进行鉴定,成功培养小鼠骨髓间充质干细胞;对造模小鼠肝脏组织进行病理切片,病理报告图示典型的肝硬化,证明造模成功;通过肝动脉和尾静脉途径移植治疗肝硬化模型小鼠,最后报告干细胞治疗的病理结果,肝硬化程度减轻,说明骨髓间充质干细胞具有一定的疗效。结论自体骨髓干细胞移植治疗肝硬化是有效的,但仍需要基础研究和大样本的临床数据。 Objective To explore the cultivation of mice bone marrow mesenchymal stem cells and the preparation of mice liver cirrhosis model, as well as the interaction of two methods. Methods First of all, the mice BMSCs were extracted to culture bottle, further separated and cultured in vitro; then, mice liver cirrhosis model was prepared by the approach of CCl4-based; finally, BMSCs were transplanted into mice liver cirrhosis model through the hepatic artery and tail vein. Results According to the expression of monoclonal antibodies, the mice BMSCs were identified by means of flow cytometry and cultured successfully; mice liver tissue was executed via pathological section, the pathological findings reported typical cirrhosis and modelled successfully; BMSCs transplantation therapy had a certain effect was proved by final pathology results and cirrhosis abated. Conclusion It is effective that autologous BMSCs transplantation treat liver cirrhosis, but basic research and a large sample of clinical data are still demanded.
出处 《肝胆胰外科杂志》 CAS 2016年第3期201-204,221,共5页 Journal of Hepatopancreatobiliary Surgery
基金 甘肃省科技重大专项项目(1302FKDA029)
关键词 骨髓间充质干细胞 肝硬化模型 小鼠 移植 bone marrow mesenchymal stem cells cirrhosis model mice transplant
  • 相关文献

参考文献12

  • 1KARAGIANNI M, K1NZEBAEH S. A comparative analsis of the adipogenie pntential in human mesenchunal stromal cellsfrom cord blood and other sources [J]. Cytotherapy, 2013, 15(1): 76-88.
  • 2XUE H L, ZENG W Z, WU X L, et al. Clinical therapeutic effects of human umbilical cord-derived mesenchymal stem cellstransplantation in the treatment of end-stage liver disease [J]. Transplant Proc, 2015, 47(2): 412-418.
  • 3ROURA S, G/i, LVEZ-MONTON C, BAYES-GENIS A. Um- bilical cord blood-derived mesenchymal stem cells: new ther- apeutic weapons for idiopathic dilated cardiomyopathy [J]. lnt J Cardiol, 2014, 177(3): 809-818.
  • 4REINDERS M E, DE FIJTER J W, ROELOFS H, et al. Au- tologons bone marrowderived Mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: resp.Lts of a phase I study [J]. Stem Cells Transl Med, 2013, 2(2): 107-111.
  • 5LEE D H, LEE M J, KIM Y S, et al. Sample rotation angle de- pendence of graphene thickness measured using atomic force microscope [J]. Carbon, 2015, 81(3): 210-215.
  • 6OTABE KOJI, NAKAHARA HIROYUKI, HASEGAWA AKIHIKO, et al. Transcription Factor Mohawk Controls Tenogenic Differentiation of Bone Marrow Mesenchymal Stem Cells In Vitro and In Vivo [J]. J Orthop Res, 2015, 33 (1): 1-8.
  • 7ANDREWS SIMON, REZA SALEHAN, MOHAMMAD. Morse Ruth. Effects of Bone Marrow-Mesenchymal Stem Cells on genotoxic sensitivity of Myeloma cells to Melphalan in vitro [J]. Mutagenesis, 2014, 29(7): 527-528.
  • 8HUA PING, WANG YOU-YU, LIU LI-BAO, et al. Invivo magnetic resonance imaging tracking of transplanted super- paramagnetic iron oxide labeled bone marrow mesenchymal stem cells in rats with myocardial infarction [J]. Mol Med Rep, 2014, 11(11): 113-120.
  • 9SVYSTONYUK D A, NGU J M, MEWHORT H E, et al. Fi- broblast growth factor-2 regpLates human cardiac myofibro- blast-mediated extracellpLar matrix remodeling [J]. J Transl Med, 2015, 13(1): 147.
  • 10SEEBER A, MARTOWCIZA A, Spizzo G, et al. Soluble Ep- CAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro [J]. BMC Cancer, 2015, 15(1): 372.

二级参考文献10

  • 1朱英,刘平.干细胞在肝脏损伤时的作用机制探讨[J].实用肝脏病杂志,2005,8(2):111-113. 被引量:4
  • 2Schwartz RE,Reyes M,Koodie L,et al. Muhipotent adult pro- genitor ceils from bone marrow differentiate into functional hepatocyte like cells. J Clin Invest,2002,109(10):1291-1302.
  • 3Fang B,Shi M,Liao L,et al. Systemic infusion of FLK1 (+) mesenchmal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation,2004,78(1):83-88.
  • 4Kollet O,Shivtiel S,Chen YQ,et al. HGF,SDF-1 and MMP-9 are involved in stress-induced human CD34^+ stem cell recruit- ment to the liver. J Clin Invest,2003,112(1): 160-169.
  • 5Alison MR,Islam S,Lira S.Stem cells in liver regeneration. Fi- brosis and cancer:the good,the bad and the ugly. J Pathol, 2009,217 : 282-298.
  • 6Terai S,Ishikawa T,Omori K,et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells, 2006,24: 2292-2298.
  • 7Gaia S,Smedile A,Omede P,et al.Feasibility and safety of G- CSF administration to induce bone marrow-derived cells mobi- lization in patients with end stage liver disease. J Hepatol, 2006,45 : 13-19.
  • 8Pal M,Zacharoulis D,Milicevic M N,et al.Autologous infusion of expanded mobilized adult bone marrow-derived CD34 cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol, 2008,103 : 1952-1958.
  • 9Kharaziha P,Hellstrim PM,Noorinayer B,et al. Improvement of liver function in liver cirrhosis patients after autologous mes- enchymal stem cell injection:a phase I-I1 clinical trial. Eur J Gastroenterol Hepatol, 2009,36:234-238.
  • 10刘卫,朱斌.自体骨髓干细胞移植治疗肝硬化研究进展[J].实用肝脏病杂志,2011,14(5):398-400. 被引量:2

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部